# Regulatory Request NIS in Korea

> **NCT03642717** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 658 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** JARDIANCE DUO®

## Key facts

- **NCT ID:** NCT03642717
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-21
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 658 (ACTUAL)
- **Last updated:** 2021-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03642717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03642717, "Regulatory Request NIS in Korea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03642717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*